中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Effect of hepatocyte transplantation in treatment of rats with liver cirrhosis and small-for-size syndrome

DOI: 10.3969/j.issn.1001-5256.2020.05.018
Research funding:

 

  • Received Date: 2019-11-29
  • Published Date: 2020-05-20
  • Objective To investigate the effect of hepatocyte transplantation(HCT) in the treatment of rats with liver cirrhosis and small-for-size syndrome(SFSS).Methods A total of 40 male Sprague-Dawley rats were given subcutaneous injection of carbon tetrachloride and oral administration of alcohol to establish a rat model of liver cirrhosis, among which 30 were randomly selected and divided into group A(hepatocyte transplantation on day 3 before surgery), group B(hepatocyte transplantation during surgery), and group C(no hepatocyte transplantation), with 10 rats in each group. All rats were given the resection of 70% of the liver, and the groups were compared in terms of survival rate, blood biochemistry at different time points, and change in liver pathological section based on HE staining. An analysis of variance was used for comparison of normally distributed continuous data between multiple groups, and the least significant differencet-test(for data with homogeneity of variance) or the Games-Howell test(for data with heterogeneity of variance) was used for further comparison between two groups; the log-rank test was used for comparison of survival rate.Results Group A had a significantly higher postoperative survival rate than groups B and C [90%(9/10) vs 50%(5/10) and 30%(3/10),χ2= 6. 440,P= 0. 04]. For groups A, B, and C at/L,904.6 ±35.6 U respectively(F =6.808,P=0. 007), the meal level of aspartate aminotransferase(AST) was 896. 3 ± 44. 7 U/L, 923. 8 ± 31. 6 U/L, and950.0 ±16.3 U/L, respectively(F= 3. 666,P= 0. 047), and the mean level of albumin(Alb) was 25. 6 ± 0. 5 g/L, 24. 8 ± 0. 6 g/L,and 23.4 ±0.4 g/L, respectively(F =26.577,P< 0. 001); group A tended to have better recovery than groups B and C, while some/L,128.2 ±20.7 U/L, and 150.5 ±14.8 U/L, respectively(F =13.816,P= 0. 001), the mean level of AST was 108. 7 ± 10. 8 U/L, 142 0±14.1 U/L, and 161.0 ±21.2 U/L, respectively(F =17.220,P< 0. 001), and the mean level of Alb was 29. 1 ± 0. 6 g/L, 28. 0 ± 0 2 g/L, and 27.0 ±0.2 g/L, respectively(F =15.629,P= 0. 001), with significant differences between the three groups. At 72 hours after surgery, liver histopathological examination showed disappearance of hepatic cord, massive hepatocyte necrosis, and inflammatory cell infil-tration in group C, while group A only had balloon-like lesions, punctate cell necrosis, and a small amount of inflammatory cell infiltra-tion.Conclusion Hepatocyte transplantation can effectively promote liver function recovery and improve survival rate of rats with liver cir-rhosis and SFSS, and its therapeutic effect is associated with the time point of transplantation.

     

  • [1] FLOHR TR, BONATTI H Jr, BRAYMAN KL, et al. The use of stem cells in liver disease[J]. Curr Opin Organ Transplant,2009, 14(1):64-71.
    [2] MAI RY, YE JZ, BAI T, et al. Advances in the prevention and treatment of posthepatectomy liver failure in patients with primary liver cancer[J]. J Clin Hepatol, 2018, 34(12):2685-2692.(in Chinese)麦荣云,叶甲舟,白涛,等.原发性肝癌肝切除术后肝衰竭的防治进展[J].临床肝胆病杂志,2018, 34(12):2685-2692.
    [3] IBARS EP, CORTES M, TOLOSA L, et al. Hepatocyte transplantation program:Lessons learned and future strategies[J].World J Gastroenterol, 2016, 22(2):874-886.
    [4] SOLTYS KA, SETOYAMA K, TAFALENG EN, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans[J]. J Hepatol, 2017, 66(5):987-1000.
    [5] DHAWAN A, STROM SC, SOKAL E, et al. Human hepatocyte transplantation[J]. Methods Mol Biol, 2010, 640:525-534.
    [6] NICOLAS CT, WANG Y, NYBERG SL. Cell therapy in chronic liver disease[J]. Curr Opin Gastroenterol, 2016, 32(3):189-194.
    [7] CARDOSO L, MOREIRA L, PINTO MA, et al. Domino hepatocyte transplantation:A therapeutic alternative for the treatment of acute liver failure[J]. Can J Gastroenterol Hepatol, 2018,2018:2593745.
    [8] ANDERSON TN, ZARRINPAR A. Hepatocyte transplantation:Past efforts, current technology, and future expansion of therapeutic potential[J]. J Surg Res, 2018, 226:48-55.
    [9] TANAKA K, OGURA Y.“Small-for-size graft” and “smallfor-size syndrome” in living donor liver transplantation[J].Yonsei Med J, 2004, 45(6):1089-1094.
    [10] KIUCHI T, TANAKA K, ITO T, et al. Small-for-size graft in living donor liver transplantation:How far should we go?[J].Liver Transpl, 2003, 9(9):s29-s35.
    [11] GOLRIZ M, ASHRAFI M, KHAJEH E, et al. Establishing a porcine model of small for size syndrome following liver resection[J]. Can J Gastroenterol Hepatol, 2017, 2017:5127178.
    [12] PAN GD, YAN LN. Problems in adult living donor liver transplantation using the right hepatic lobe[J]. Hepatobiliary Pancreat Dis Int, 2006, 5(3):345-349.
    [13] XU XL, WANG ZX, ZHOU Y, et al. Reconsideration of liver failure after liver cancer surgery[J]. J Clin Hepatol, 2018, 34(9):2008-2011.(in Chineae)许晓磊,王志鑫,周灜,等.对肝癌术后肝衰竭的再认识[J].临床肝胆病杂志,2018, 34(9):2008-2011.
    [14] CHEN XP, XIANG S, HUANG ZY. Investigation of extent of liver resection for liver cancer combined with liver cirrhosis[J].Chin J Dig Surg, 2019, 18(4):303-306.(in Chineae)陈孝平,项帅,黄志勇.肝癌合并肝硬化肝切除范围的探讨[J].中华消化外科杂志,2019, 18(4):303-306.
    [15] XU Y, REN ZH, YU ZM, et al. Role of somatostatin in protecting small-for-size liver after hepatectomy in rats with cirrhosis[J]. Chin J Hepatobiliary Surg, 2017, 23(8):542-547.(in Chinese)徐勇,任祖海,俞照妹,等.生长抑素对肝硬化大鼠肝切除术后小体积肝的保护作用[J].中华肝胆外科杂志,2017, 23(8):542-547.
    [16] LI XC, WANG HW, LI CX. Present situation and prospect of comprehensive treatment of hepatocellular carcinoma[J].chin J Dig Surg, 2018, 17(5):433-436.(in Chinese)李相成,王宏伟,李长贤.肝癌综合治疗的现状与展望[J].中华消化外科杂志,2018, 17(5):433-436.
  • Relative Articles

    [1]Weiming DAI, Lungen LU, Xiaobo CAI. Association between liver sinusoidal endothelial cells and liver fibrosis[J]. Journal of Clinical Hepatology, 2023, 39(2): 419-423. doi: 10.3969/j.issn.1001-5256.2023.02.027
    [2]Yu ZHANG, Huali WANG, Shuming LU. Three cases of hepatic epithelioid hemangioendothelioma[J]. Journal of Clinical Hepatology, 2022, 38(9): 2116-2119. doi: 10.3969/j.issn.1001-5256.2022.09.031
    [3]Hao XU, Bai RUAN, Zhiwen LI, Zhiqiang FANG, Lin WANG, Kefeng DOU. Establishment of a mouse model of vascular endothelial-mesenchymal transdifferentiation genetic tracing and its role in liver fibrosis studies[J]. Journal of Clinical Hepatology, 2022, 38(4): 832-836. doi: 10.3969/j.issn.1001-5256.2022.04.018
    [4]Jin XU, Yan PENG, Chuankang TANG. Value of neutrophil-lymphocyte ratio combined with apolipoprotein A-I level in predicting the severity of acute pancreatitis in the early stage after admission[J]. Journal of Clinical Hepatology, 2021, 37(3): 660-665. doi: 10.3969/j.issn.1001-5256.2021.03.030
    [5]Wei BiWei, Gong YaHui, Liang ZhiHai. Role of pyroptosis in the pathogenesis of acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1905-1908. doi: 10.3969/j.issn.1001-5256.2020.08.050
    [6]Qi QinQin, Yang Bin, Li HuiHui, Bao JunJun, Li HongYe, Wang BingBing, Mei Qiao. Level of platelet microparticles in acute pancreatitis and their role in the formation of neutrophil extracellular traps[J]. Journal of Clinical Hepatology, 2020, 36(4): 870-873. doi: 10.3969/j.issn.1001-5256.2020.04.032
    [7]Jiang Zhao, Ruan Bo. The role of liver sinusoidal endothelial cells in the progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(3): 684-686. doi: 10.3969/j.issn.1001-5256.2020.03.047
    [8]Zhu ZiYi, Liu Yuan, Wang WenBo, Jiang ZhongYong, Chang Kai, Ye YuSheng, Xiong Jie. Mechanism of HCV stimulation of human umbilical vein endothelial cells in the pathogenesis of atherosclerosis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1313-1317. doi: 10.3969/j.issn.1001-5256.2019.06.026
    [9]Yu ZiYue, Lin Xin, Han Ying, Cui LiNa. Role of liver sinusoidal endothelial cells in liver regeneration and the development of liver fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(9): 2072-2074. doi: 10.3969/j.issn.1001-5256.2019.09.041
    [10]Wang Lin, Liu XueEn, Zhuang Hui. Cellular mechanisms in liver fibrosis regression[J]. Journal of Clinical Hepatology, 2018, 34(4): 862-866. doi: 10.3969/j.issn.1001-5256.2018.04.036
    [11]Zhu ZeMin, Xie ZhiQin, Zhao ZhiJian, Li HongXia, Xu Tao, Tang CaiXi. Pancreatic acinar cell carcinoma with acute pancreatitis as the first symptom: A case report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2662-2664. doi: 10.3969/j.issn.1001-5256.2018.12.032
    [12]Hu QingMei, Niu ChunYan. Predictive value of combined measurement of D-dimer, fibrinogen, and peripheral blood leukocyte count for severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2017, 33(8): 1522-1526. doi: 10.3969/j.issn.1001-5256.2017.08.023
    [13]Wang Yan, Cui LiJian, Xiao HongLi, Wang GuoXing, Yin ChengHong. Effect of angiotensin 1-7 on the TLR4/NF-κB pathway in cerulein-induced pancreatic acinar cells[J]. Journal of Clinical Hepatology, 2016, 32(11): 2146-2150. doi: 10.3969/j.issn.1001-5256.2016.11.029
    [14]Jiao ShuHua, Liu PengLiang, Wen YanHui. Combined determination of serum C-reactive protein,lipase,interleukin-1β,and intercellular adhesion molecule1 in early identification of severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2016, 32(1): 131-134. doi: 10.3969/j.issn.1001-5256.2016.01.025
    [15]Hao TingTing, Ma XiaoPeng, Wen YanLi, Dai GuangRong, Feng YiChao, Zhang Li. Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis[J]. Journal of Clinical Hepatology, 2016, 32(2): 329-332. doi: 10.3969/j.issn.1001-5256.2016.02.027
    [16]Lu Wang, Zhang Rui, Jiang HongLi, Hu YuLin, Xin GuiJie. One case of hepatic epithelioid hemangioendothelioma[J]. Journal of Clinical Hepatology, 2015, 31(8): 1330-1331. doi: 10.3969/j.issn.1001-5256.2015.08.038
    [17]Wu Gang, Zheng Jie, Hu GuoXin, Peng YanZhong. Role of liver nonparenchymal cells in hepatic ischemia-reperfusion injury[J]. Journal of Clinical Hepatology, 2014, 30(12): 1366-1369. doi: 10.3969/j.issn.1001-5256.2014.12.033
    [18]Ren LiNan, Guo XiaoZhong, Zou DeLi. EG-VEGF expression and significance in pancreatic carcinoma[J]. Journal of Clinical Hepatology, 2012, 28(8): 589-591.
  • Cited by

    Periodical cited type(15)

    1. 许娟,闫涛涛,李严锋,侯静涛,樊研. ALBI评分联合PCT在肝硬化腹水患者自发性细菌性腹膜炎的预测作用. 胃肠病学和肝病学杂志. 2023(01): 85-89 .
    2. 周苏云,周影,程新月. 肝硬化患者发生肝性脑病的影响因素分析及对预检分诊意义的探讨. 中西医结合护理(中英文). 2023(03): 130-132 .
    3. 方翊天,吴若林,黄帆,王国斌,冯丽娟,余孝俊,侯刘进,叶征辉,耿小平,赵红川. 肝移植术后多重耐药菌感染危险因素的单中心临床研究. 器官移植. 2021(02): 197-202 .
    4. 李尚书,刘群,黄丽雯. 慢性肝病血小板减少的原因. 中国肝脏病杂志(电子版). 2021(02): 24-28 .
    5. 陆素芳,周红,王丹丹,陈益群,赵红利,张勇杨. MELD评分联合SII对失代偿期肝硬化患者预后的预测作用. 现代消化及介入诊疗. 2021(08): 973-977 .
    6. 黄敏,李冬冬,刘传苗. 乙肝相关慢加急性肝衰竭患者临床短期预后因素的分析. 中华全科医学. 2021(12): 2028-2030 .
    7. 贾亚男,李瀚,李先亮,贺强. 危重症肝病肝移植患者诊断和评估标准的临床进展. 器官移植. 2020(03): 326-331+368 .
    8. 姚运海,赵卫峰,甘建和. 苏州地区血吸虫性肝病患者临床特征及外周血T淋巴细胞亚群分布. 中国血吸虫病防治杂志. 2020(02): 154-158+167 .
    9. 张耀弟. △CTP评分评估肝硬化患者短期预后的价值分析. 甘肃科技. 2020(09): 117-118+152 .
    10. 刘小婷,杨欢,姚红,任小婵,罗选娟,王小闯. 碳青霉烯类耐药肺炎克雷伯菌感染死亡风险预测模型的建立及其对患者预后的预测价值研究. 中国全科医学. 2020(30): 3789-3797 .
    11. 韩志钧,韩柠泽,闫伟,马金彤. 肝血流动力学变化与肝储备功能相关性的研究. 中华医学超声杂志(电子版). 2020(06): 563-565 .
    12. 寇建涛,刘喆,朱继巧,马军,许文犁,李瀚,贾亚男,李先亮,贺强. 肝移植治疗危重症肝病的临床疗效研究. 器官移植. 2020(04): 482-486 .
    13. 宋梅,汪明星,李乐,何进伟,何丽丽. MELD评分结合降钙素原评估终末期肝病预后的临床分析. 中国医药科学. 2020(09): 254-256 .
    14. 李帆,成金英,刘贤贤,丁国锋. 乙肝肝硬化并发甲型流感及肺曲霉菌病1例并文献复习. 中国当代医药. 2020(34): 214-217 .
    15. 韩志钧,韩柠泽,闫伟,马金彤. 肝血流动力学变化与吲哚菁绿代谢试验评价肝储备功能的对比. 医学研究与教育. 2019(06): 28-31 .

    Other cited types(1)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 24.8 %FULLTEXT: 24.8 %META: 69.6 %META: 69.6 %PDF: 5.5 %PDF: 5.5 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 8.3 %其他: 8.3 %其他: 1.6 %其他: 1.6 %China: 0.8 %China: 0.8 %Russian Federation: 0.3 %Russian Federation: 0.3 %[]: 0.5 %[]: 0.5 %三亚: 0.2 %三亚: 0.2 %上海: 1.8 %上海: 1.8 %中卫: 0.2 %中卫: 0.2 %佛山: 0.2 %佛山: 0.2 %兰州: 0.3 %兰州: 0.3 %北京: 4.4 %北京: 4.4 %南京: 1.3 %南京: 1.3 %南宁: 0.3 %南宁: 0.3 %南阳: 0.2 %南阳: 0.2 %卡纳塔克: 0.2 %卡纳塔克: 0.2 %台州: 0.2 %台州: 0.2 %合肥: 1.5 %合肥: 1.5 %吉林: 0.5 %吉林: 0.5 %呼和浩特: 0.3 %呼和浩特: 0.3 %唐山: 0.2 %唐山: 0.2 %商丘: 0.2 %商丘: 0.2 %大连: 0.2 %大连: 0.2 %天津: 0.2 %天津: 0.2 %太原: 0.2 %太原: 0.2 %宁波: 0.2 %宁波: 0.2 %安康: 0.2 %安康: 0.2 %安阳: 0.2 %安阳: 0.2 %宣城: 0.3 %宣城: 0.3 %密蘇里城: 1.1 %密蘇里城: 1.1 %巴黎: 0.5 %巴黎: 0.5 %常德: 0.2 %常德: 0.2 %广州: 0.3 %广州: 0.3 %张家口: 4.4 %张家口: 4.4 %德罕: 0.2 %德罕: 0.2 %成都: 0.5 %成都: 0.5 %扬州: 0.2 %扬州: 0.2 %拉斯维加斯: 0.5 %拉斯维加斯: 0.5 %昆明: 0.2 %昆明: 0.2 %杭州: 0.2 %杭州: 0.2 %武汉: 1.1 %武汉: 1.1 %洛阳: 0.3 %洛阳: 0.3 %济南: 0.2 %济南: 0.2 %海得拉巴: 0.5 %海得拉巴: 0.5 %湖州: 0.2 %湖州: 0.2 %湘潭: 0.2 %湘潭: 0.2 %湛江: 0.2 %湛江: 0.2 %漯河: 0.2 %漯河: 0.2 %福州: 0.2 %福州: 0.2 %罗奥尔凯埃: 0.2 %罗奥尔凯埃: 0.2 %自贡: 0.2 %自贡: 0.2 %芒廷维尤: 43.0 %芒廷维尤: 43.0 %芝加哥: 0.5 %芝加哥: 0.5 %苏州: 0.2 %苏州: 0.2 %茂名: 0.2 %茂名: 0.2 %莫斯科: 3.6 %莫斯科: 3.6 %西宁: 10.4 %西宁: 10.4 %诺沃克: 0.6 %诺沃克: 0.6 %贵阳: 0.2 %贵阳: 0.2 %运城: 2.3 %运城: 2.3 %金华: 0.3 %金华: 0.3 %长春: 1.8 %长春: 1.8 %长沙: 0.5 %长沙: 0.5 %长治: 0.2 %长治: 0.2 %马湾: 0.2 %马湾: 0.2 %马鞍山: 0.2 %马鞍山: 0.2 %黔西南: 0.2 %黔西南: 0.2 %其他其他ChinaRussian Federation[]三亚上海中卫佛山兰州北京南京南宁南阳卡纳塔克台州合肥吉林呼和浩特唐山商丘大连天津太原宁波安康安阳宣城密蘇里城巴黎常德广州张家口德罕成都扬州拉斯维加斯昆明杭州武汉洛阳济南海得拉巴湖州湘潭湛江漯河福州罗奥尔凯埃自贡芒廷维尤芝加哥苏州茂名莫斯科西宁诺沃克贵阳运城金华长春长沙长治马湾马鞍山黔西南

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (908) PDF downloads(153) Cited by(16)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return